Charles Schwab Investment Management Inc Amgen Inc Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 13,205,604 shares of AMGN stock, worth $3.92 Billion. This represents 0.65% of its overall portfolio holdings.
Number of Shares
13,205,604
Previous 10,532,629
25.38%
Holding current value
$3.92 Billion
Previous $3.39 Billion
1.42%
% of portfolio
0.65%
Previous 0.66%
Shares
30 transactions
Others Institutions Holding AMGN
# of Institutions
3,124Shares Held
417MCall Options Held
8.84MPut Options Held
6.55M-
Vanguard Group Inc Valley Forge, PA52.7MShares$15.7 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.7 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.71 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.36 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA13MShares$3.86 Billion2.68% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $159B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...